3Z is a preclinical drug company focusing on the discovery of Central Nervous System (CNS) drugs. It provides pharmaceutical companies with expert services in high throughput screening of small molecule libraries for CNS effects.

By automatically monitoring behavior in thousands of zebrafish larvae over 24 hours, using custom built data analysis routines, 3Z can quickly and cost effectively screen thousands of compounds in vivo, significantly reducing the cost and time of CNS drug discovery.

The method developed by 3Z combines the cost efficiency and efficacy of in-vitro tests with the high information content of in vivo testing. 

 

Comments are closed.